Insights on the Molecular Diagnostics for Infectious Disease Global Market to 2026 - Aging Population a Boon for All Diagnostics
January 16, 2023 07:38 ET | Research and Markets
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country. With COVID-19 Impact & Forecasting/Analysis, and Executive...
Syndromic Multiplex Panels Global Market Report 2023: Lower Costs and Point of Care Advantage Drives Adoption
January 16, 2023 07:18 ET | Research and Markets
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The " Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, Gi Etc.) by Place, by Product and by Country....
Veru Announces Appointment of Dr. David D. Ho as Chairman of its Infectious Disease Scientific Advisory Board
January 10, 2023 08:30 ET | Veru Inc.
MIAMI. FL, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for...
Syndromic Multiplex Diagnostic Global Market Report 2023: Speed of Diagnosis and Lower Costs Drive Adoption
January 05, 2023 08:48 ET | Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country,...
Professor Jackie Yi-Ru Ying
Two Female Scientists Win this year’s King Faisal Prize
January 04, 2023 13:57 ET | King Faisal Prize
Jeddah, Saudi Arabia, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Two women scientists were announced King Faisal Prize for Medicine and Science laureates for 2023: a Covid-19 vaccine developer and a...
OTC/DTC Infectious Disease Diagnostics Market Report 2023: New Sampling Technology and Rapid and Multiplex Tests Present Opportunities
January 04, 2023 07:03 ET | Research and Markets
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country. With Market...
Assembly Biosciences Announces Promising Interim Results from Two Clinical Trials Evaluating Highly Potent Next-Generation Core Inhibitor Candidates ABI-H3733 and ABI-4334
December 19, 2022 08:00 ET | Assembly Biosciences, Inc.
In initial ABI-H3733 cohort of 50 mg in 28-day Phase 1b study, six of eight HBV patients on treatment reached lower limit of quantification for HBV DNA by day 21 and patients showed a mean reduction...
New Logo.png
Provectus Biopharmaceuticals Announces Decision to Not Undertake Reverse Split of Outstanding and Authorized Equities in 2022; Expects to Seek Same Stockholder Approval Again in 2023
December 12, 2022 08:00 ET | Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company’s Board of Directors (Board) has decided to not undertake the reverse stock split and...
Assembly Biosciences Reports Third Quarter 2022 Financial Results and Recent Highlights and Announces Upcoming Conference Participation
November 08, 2022 16:05 ET | Assembly Biosciences, Inc.
Phase 1a Trial of Next-Generation Core Inhibitor, ABI-4334, Now Underway Following Clinical Trial Application (CTA) Clearance SOUTH SAN FRANCISCO, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Assembly...
Virology Specimen Collection Global Market to Reach $6.76 Billion by 2026 at a CAGR of 4%
November 04, 2022 09:18 ET | Research and Markets
Dublin, Nov. 04, 2022 (GLOBE NEWSWIRE) -- The "Virology Specimen Collection Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global virology specimen...